Pancreatic Disease Risk Increased by Type 2 Diabetes Drug Byetta
Byetta, a drug commonly prescribed for the treatment of type 2 (adult onset) diabetes, has been linked to an increased risk of deadly pancreatic disease. Dozens of Byetta patients have suffered a...
View ArticleFDA Orders Revisions to Januvia and Janumet Labeling for Acute Pancreatitis
The Food and Drug Administration is warning about dozens of cases of acute pancreatitis reported in people taking the Type 2 diabetes drugs Januvia and Janumet. Januvia (sitagliptin) and Janumet...
View ArticleKidney Injury Risks Behind Label Change for Type 2 Diabetes Drug Byetta
Labeling on the type 2 diabetes drug Byetta has been changed to include the risk of kidney functioning problems, the Food and Drug Administration said. Byetta, known chemically as exenatide, is made by...
View ArticleFDA Warns About Misleading Ads for Byetta, Cymbalta
The Food and Drug Administration today issued warning letters to the makers of the diabetes drug Byetta and the depression drug Cymbalta for what the agency says are false and misleading advertising...
View Article